References
Braak H, Braak E. Neuropsychological stageing of Alzheimer-related changes. Acta Neuropathol, 1991; 82: 239–259.
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound -B. Ann Neurol 2004;55(3):306–319.
Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment. Clinical characterization an outcome. Arch Neurol 1999, 56: 303–308.
Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer’s disease? Lancet Neurol 2004; 3: 246–248.
Jicha G, Parisi JE, Dickson DW, et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Neurobiol Aging. 2004; 25(S2): S135.
Dubois B, Feldman H, Jacova C et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007 Aug;6(8):734–46
Sarazin M, Berr C, de Rotrou J et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study. Neurology. 2007 Nov 6;69(19):1859–1867.
Bowman FH, Verwey NA, Klein et al. New research criteria for the diagnosis of Alzheimer’s disease applied in a memory clinic population. ICAD 2008, 26–31, 2008 Chicago.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dubois, B. Interest of the new criteria for drug trials in AD. J Nutr Health Aging 13, 356–357 (2009). https://doi.org/10.1007/s12603-009-0042-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-009-0042-9